Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction
Source: Originally published on Quantum Computing Report on August 1, 2026.
Researchers from the Cleveland Clinic and IBM Research have developed a quantum machine learning framework to predict which tumor gene mutations generate immunogenic neoantigens—abnormal cell-surface proteins that trigger a therapeutic T-cell immune response. Published in Science Advances under the title "Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural network," the [...] The post Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction appeared first on Quantum Computing Report....
To read the full article, visit the original source page: